Moxifloxacin concentration correlate with QTc interval in rifampicin-resistant tuberculosis patients on shorter treatment regimens

• Main Authors: Tutik Kusmiati, Tutik, Ni Made Mertaniasih, Ni Made, Johanes Nugroho Eko Putranto, Johanes, Budi Suprapti, Budi, Nadya Luthfah, Nadya, Soedarsono, Soedarsono, Winariani Koesoemoprodjo, Winariani, Aryani Prawita Sari, Aryani
• Format: Article PeerReviewed
• Language: English; English; Indonesian
• Published: Elsevier
• Subjects: R5-920 Medicine (General)
• Online Access: https://repository.unair.ac.id/120137/1/17%20artikel_.pdf; https://repository.unair.ac.id/120137/2/17%20turnitin.pdf; https://repository.unair.ac.id/120137/3/17%20karil.pdf; https://repository.unair.ac.id/120137/; https://www.sciencedirect.com/science/article/pii/S2405579422000250?via%3Dihub; https://doi.org/10.1016/j.jctube.2022.100320
• Institution: Universitas Airlangga

Abstract Background: Drug-resistant tuberculosis (DR-TB) continues to be a global threat. Moxifloxacin is one of the components of the shorter treatment regimen which is suspected to increase the risk of QT prolongation, although it is also likely to be the most effective against DR-TB. A study to...